A clinical study to evaluate efficacy of a polyherbal ayurvedic formulation in the treatment of Madhumeha ( type 2 diabetes mellitus)

Preclinical and Clinical Study To Determine The Safety and Efficacy of a Polyherbal Formulation in the Treatment of Madhumeha(Type 2 diabetes Mellitus) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086956

Enrollment

Registered

2025-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Recently diagnosed ( less than 6 months)cases of type 2 diabetes mellitus not taking any anti-diabetic drug and if yes in any of the three- blood sugar fasting more than 126mg/dl and more than equal 200mg/dl, PPBS more than 200 mg/dl and less than equal 350mg/dl or glycated hemoglobin more than 7 percentage and less than 10 percentage

Exclusion criteria

Exclusion criteria: 1.if yes in any of the three- blood sugar fasting less than equal 126mg/dl and more than equal 200mg/dl, PPBS less than equal 200 mg/dl and more than equal 350mg/dl or glycated hemoglobin less than equal 7 percentage and more than equal 10 percentage 2.Malignant and accelerated hypertensive 3.CVS disorder (CAD) 4.Pregnant women and planning to be pregnant within six months 5.Lectating mother 6.Secondary diabetes mellitus 7.patient undergoing regular treatment for diabetes mellitus or any other severe illness 8. CNS disorder

Design outcomes

Primary

Measure	Time frame
The primary outcome will be measured based on clinical outcome, Biochemical outcome, hematological outcome measures safety and tolerability measures to determine the effectiveness and safety of the test drug for the treatment of Madhumeha (Type 2 Diabetes mellitus)Timepoint: 56 days	—

Secondary

Measure	Time frame
The effect of test drug medication alters the quality of life that will be evaluated after completion of the treatment.Timepoint: 56 days	—

Countries

India

Contacts

Public ContactDr Susmita Sarkar

Institute of Post Graduate Ayurvedic Education and Research at S.V.S.P. Hospital

atipgaer@gmail.com9874849650

Outcome results